Grant round 2024

We are delighted to announce a call for research proposals for our new 2024 Grant Round.

Neuroblastoma UK invites applications across the breadth of our research remit to facilitate the development of new and improved treatments for children with neuroblastoma. Our emphasis for this grant call is on translational research which can be rapidly applied to the clinical setting in the short to medium term. We are especially interested in applications that aim to develop new therapeutic approaches, improve existing treatments or explore treatment synergies.

We expect a typical award to be in the region of £200k - £250k for a project duration of up to 3 years but there is no defined upper limit. Decisions will be made on the quality of the proposed research and its perceived impact, rather than cost parameters alone.

Criteria

• The lead applicant must be based in a UK or Republic of Ireland (ROI) laboratory

• We particularly encourage international co-applicants and collaborators for this grant round, who will bring expertise not available in the UK or ROI.

• Applications may contain requests for funding some work outside the UK or ROI, provided all costs are quoted in sterling at a fixed rate but the Award must be administered by the UK lead laboratory.

• Grants will be evaluated by peer review and by our Scientific Advisory Board before a final decision is made by the Neuroblastoma UK Board of Trustees.

Application process

All successful applicants are expected to adhere to our Grant Awards Terms and Conditions which are available online.

Important dates

Deadline for applications: 3rd June 2024.

We expect to inform applicants about the Awards by the end of October 2024. For any enquiries about the funding call or application process, please email grants@neuroblastoma.org.uk.